A Double-blind, Placebo-Controlled, Parallel-group, Randomized, Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of BMS-770767 in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Either Diet and Exercise Alone or on a Background of Metformin.
Phase of Trial: Phase II
Latest Information Update: 14 Oct 2015
At a glance
- Drugs BMS 770767; Metformin
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 23 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jan 2011 Planned end date changed from 1 Feb 2011 to 1 Jan 2011 as reported by ClinicalTrials.gov.